Washington, D.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- This month marks a major milestone in cardiovascular medicine: 25 years ...

W. L. Gore & Associates' medical business (Gore) today announced trial results evaluating the investigational GORE® VIABAHN® ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.

Please provide your email address to receive an email when new articles are posted on . W.L. Gore and Associates announced that the FDA has approved the Tigris Vascular Stent for the treatment of ...

A stent while you’re stable may prevent urgent care. For some people with stable coronary artery disease (CAD), having a stent or stents put in now along with standard medical therapy significantly ...

While existing vascular stents, made of metal, come in different sizes to accommodate a variety of patients, a new technology offers complete personalization according to an individual’s precise ...

Contego Medical announced late-breaking clinical results from the PERFORMANCE III carotid stent study. At 30 days, the 146 patients in the study had no strokes or myocardial infarctions, and there ...

Vascular stent implantation is feasible and likely to provide clinical benefit in select patients who have central vascular obstruction due to fibrosing mediastinitis (FM), according to the first ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9r4nlm/medipoint) has announced the addition of the "MediPoint: Peripheral ...

According to Report Ocean, global vascular stent market is expected to reach USD 10,984.67 million by the end of 2026, expanding at a CAGR of 6.68% over the forecast period i.e. 2020 2026. The Market ...